12 Health Care Stocks Moving In Friday's After-Market Session
Profusa Abstract Accepted For LINC 2026; Presentation To Highlight Tissue Oxygen Monitoring Insights In PAD Pilot Study
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
12 Health Care Stocks Moving In Monday's After-Market Session
Profusa To Present Abstract Titled 'Monitoring Tissue Oxygen Dynamics With a Novel Implantable Hydrogel Sensor in Patients With Peripheral Arterial Disease ' At Paris Vascular Insights 2025
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
12 Health Care Stocks Moving In Thursday's Intraday Session
Profusa CEO Says 'Co To Capitalize On The Near-Term European And U.S. Lumee Oxygen Opportunity To Deliver 2026 Potential Revenue Of $500K To $2M And $9M To $13M Potential Revenue In 2027
Express News | Profusa Inc - Targets $200-$250 Mln Revenue by 2030
Profusa 3Q Loss/Shr 70c >PFSA
Profusa Announces Third Quarter Business and Financial Highlights
10-Q: Quarterly report
Profusa Delays Filing of Quarterly Report
Express News | Profusa Inc - to Commercialize Lumee in EU in 2Q 2026
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee Oxygen and Glucose Monitoring Launches
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
Why Profusa (PFSA) Stock Soared 36% After Hours?
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Profusa Unveils Strategic Focus in Investor Update